To hear about similar clinical trials, please enter your email below

Trial Title: A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

NCT ID: NCT06425302

Condition: Lymphoma, Follicular

Conditions: Official terms:
Lymphoma
Lymphoma, Follicular
Prednisone
Cyclophosphamide
Bendamustine Hydrochloride
Rituximab
Doxorubicin
Liposomal doxorubicin
Vincristine

Conditions: Keywords:
Follicular lymphoma
Grade 1-3a Follicular lymphoma
BMS-986369
CC-99282
Lymphoma

Study type: Interventional

Study phase: Phase 2

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Treatment

Masking: None (Open Label)

Intervention:

Intervention type: Drug
Intervention name: Golcadomide
Description: Specified dose on specified days
Arm group label: Golcadomide Dose 1 + Rituximab
Arm group label: Golcadomide Dose 2 + Rituximab

Other name: CC-99282

Other name: BMS-986369

Intervention type: Drug
Intervention name: Rituximab
Description: Specified dose on specified days
Arm group label: Golcadomide Dose 1 + Rituximab
Arm group label: Golcadomide Dose 2 + Rituximab
Arm group label: Rituximab + Chemotherapy

Other name: Mabthera

Intervention type: Drug
Intervention name: Cyclophosphamide
Description: Specified dose on specified days
Arm group label: Rituximab + Chemotherapy

Other name: Endoxan

Intervention type: Drug
Intervention name: Doxorubicin
Description: Specified dose on specified days
Arm group label: Rituximab + Chemotherapy

Other name: Caelyx

Other name: pegylated liposomal doxorubicin

Other name: PLD

Intervention type: Drug
Intervention name: Vincristine
Description: Specified dose on specified days
Arm group label: Rituximab + Chemotherapy

Intervention type: Drug
Intervention name: Prednisone
Description: Specified dose on specified days
Arm group label: Rituximab + Chemotherapy

Intervention type: Drug
Intervention name: Bendamustine
Description: Specified dose on specified days
Arm group label: Rituximab + Chemotherapy

Summary: The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).

Criteria for eligibility:
Criteria:
Inclusion Criteria - Participant has histologically confirmed Grade 1, 2 or 3a follicular lymphoma (FL) or classic FL. Formalin-fixed paraffin embedded (FFPE) archival tissue from 1 year prior to screening is allowed. If more than 1 year has passed, then a fresh biopsy must be obtained to confirm the diagnosis. - Have no prior systemic treatment for follicular lymphoma. Prior radiation therapy or surgery for previously diagnosed stage I disease is acceptable. - Stage II to IV disease. - Deemed to need treatment by treating investigator. Reasons for treatment can include, but are not limited to, the following:. i) Bulky disease defined as:. A. A nodal or extra nodal (except spleen) mass > 7cm in its greater diameter or, involvement of at least 3 nodal or extra nodal sites (each with a diameter greater than >3 cm). ii) Presence of at least one of the following B symptoms:. A. Fever (>38°C) of unclear etiology. B. Night sweats. C. Weight loss greater than 10% within the prior 6 months. iii) Splenomegaly with inferior margin below the umbilical line. iv) Any one of the following cytopenia due to lymphoma:. A. Platelets <100,000 cells/mm3 (100 x 109/L). B. Absolute neutrophil count (ANC) < 1,500 cells/mm3 (1.5 x 109/L). C. Hemoglobin < 10g/dL (6.25 mmol/L). v) Pleural or peritoneal serous effusion (irrespective of cell content). vi) Any compressive syndrome (for example, but not restricted to ureteral, orbital, gastrointestinal). Exclusion Criteria - Clinical evidence of transformed lymphoma by investigator assessment. - Follicular Large Cell as per WHO 5th classification or Grade 3b follicular lymphoma as per WHO 4th classification. - Participant has any significant medical condition, active infection, laboratory abnormality, or psychiatric illness that would prevent the participation in the study. - Other protocol-defined Inclusion/Exclusion criteria apply.

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Local Institution - 0152

Address:
City: Birmingham
Zip: 35294-3300
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0152

Facility:
Name: Alaska Oncology and Hematology

Address:
City: Anchorage
Zip: 99508
Country: United States

Status: Recruiting

Contact:
Last name: Steven Liu, Site 0055

Phone: 907-257-9851

Facility:
Name: Mayo Clinic in Arizona - Phoenix

Address:
City: Phoenix
Zip: 85054
Country: United States

Status: Recruiting

Contact:
Last name: Talal Hilal, Site 0180

Phone: 480-301-8000

Facility:
Name: Local Institution - 0190

Address:
City: Tucson
Zip: 85711
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0190

Facility:
Name: Local Institution - 0035

Address:
City: San Francisco
Zip: 94143
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0035

Facility:
Name: Local Institution - 0022

Address:
City: Washington
Zip: 20007
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0022

Facility:
Name: Local Institution - 0209

Address:
City: Fort Myers
Zip: 33901
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0209

Facility:
Name: Mayo Clinic in Florida

Address:
City: Jacksonville
Zip: 32224
Country: United States

Status: Recruiting

Contact:
Last name: Muhamad Alhaj Moustafa, Site 0005

Phone: 904-953-2000

Facility:
Name: Local Institution - 0210

Address:
City: Saint Petersburg
Zip: 33705
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0210

Facility:
Name: Tampa General Hospital

Address:
City: Tampa
Zip: 33606
Country: United States

Status: Recruiting

Contact:
Last name: Daniel Kerr, Site 0026

Phone: 813-844-7585

Facility:
Name: Local Institution - 0208

Address:
City: West Palm Beach
Zip: 33401
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0208

Facility:
Name: Local Institution - 0019

Address:
City: Fairway
Zip: 66205
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0019

Facility:
Name: Local Institution - 0173

Address:
City: Jefferson
Zip: 70121
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0173

Facility:
Name: Local Institution - 0033

Address:
City: Baltimore
Zip: 21287
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0033

Facility:
Name: Local Institution - 0001

Address:
City: Boston
Zip: 02114
Country: United States

Status: Withdrawn

Facility:
Name: Local Institution - 0004

Address:
City: Boston
Zip: 02114
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0004

Facility:
Name: Mayo Clinic in Rochester, Minnesota

Address:
City: Rochester
Zip: 55905
Country: United States

Status: Recruiting

Contact:
Last name: J. C. Villasboas, Site 0031

Phone: 507-284-4392

Facility:
Name: Comprehensive Cancer Centers Of Nevada

Address:
City: Henderson
Zip: 89074
Country: United States

Status: Recruiting

Contact:
Last name: Edwin Kingsley, Site 0111

Phone: 702-952-1251

Facility:
Name: John Theurer Cancer Center at Hackensack University Medical Center

Address:
City: Hackensack
Zip: 07601
Country: United States

Status: Recruiting

Contact:
Last name: Lori Leslie, Site 0183

Phone: 201-341-5859

Facility:
Name: Local Institution - 0020

Address:
City: New Brunswick
Zip: 08903
Country: United States

Status: Withdrawn

Facility:
Name: Local Institution - 0036

Address:
City: New York
Zip: 10029
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0036

Facility:
Name: Local Institution - 0052

Address:
City: Salt Lake City
Zip: 84106
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0052

Facility:
Name: Local Institution - 0200

Address:
City: Norfolk
Zip: 23502
Country: United States

Status: Withdrawn

Facility:
Name: Local Institution - 0201

Address:
City: Norfolk
Zip: 23502
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0201

Facility:
Name: Local Institution - 0166

Address:
City: Seattle
Zip: 98104
Country: United States

Status: Withdrawn

Facility:
Name: Local Institution - 0202

Address:
City: Seattle
Zip: 98109
Country: United States

Status: Not yet recruiting

Contact:
Last name: Site 0202

Facility:
Name: Liverpool Hospital

Address:
City: Liverpool
Zip: 2170
Country: Australia

Status: Recruiting

Contact:
Last name: Ashlea Campbell, Site 0046

Phone: 0405814856

Facility:
Name: Mater Misercordiae Hospital

Address:
City: South Brisbane
Zip: 4101
Country: Australia

Status: Recruiting

Contact:
Last name: Stephen Boyle, Site 0070

Phone: 0731638111

Facility:
Name: Latrobe Regional Health

Address:
City: Traralgon
Zip: 3844
Country: Australia

Status: Recruiting

Contact:
Last name: Amanda Ormerod, Site 0181

Phone: +61351738111

Facility:
Name: Local Institution - 0061

Address:
City: Porto Alegre
Zip: 90035-903
Country: Brazil

Status: Not yet recruiting

Contact:
Last name: Site 0061

Facility:
Name: Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA

Address:
City: Rio de Janeiro
Zip: 22250-905
Country: Brazil

Status: Recruiting

Contact:
Last name: Adriana Scheliga, Site 0060

Phone: 552199732115

Facility:
Name: Instituto D'Or de Pesquisa e Ensino (IDOR)

Address:
City: Sao Paulo
Zip: 04543-000
Country: Brazil

Status: Recruiting

Contact:
Last name: Abel Costa, Site 0058

Phone: +5511964999091

Facility:
Name: Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein

Address:
City: São Paulo
Zip: 05652-900
Country: Brazil

Status: Recruiting

Contact:
Last name: Guilherme Perini, Site 0056

Phone: +5511992926463

Facility:
Name: Princess Margaret Cancer Centre

Address:
City: Toronto
Zip: M5G 2M9
Country: Canada

Status: Recruiting

Contact:
Last name: Robert Kridel, Site 0064

Phone: 41694645012243

Facility:
Name: Local Institution - 0205

Address:
City: Chicoutimi
Zip: G7H 5H6
Country: Canada

Status: Not yet recruiting

Contact:
Last name: Site 0205

Facility:
Name: Fundacion Arturo Lopez Perez (FALP)

Address:
City: Santiago
Zip: 7500921
Country: Chile

Status: Recruiting

Contact:
Last name: Raimundo Gazitua, Site 0049

Phone: +56984290128

Facility:
Name: Clínica Inmunocel

Address:
City: Santiago
Zip: 7580206
Country: Chile

Status: Recruiting

Contact:
Last name: Alejandro Berkovits, Site 0050

Phone: 997890202

Facility:
Name: Local Institution - 0101

Address:
City: Saint-Cloud
Zip: 92210
Country: France

Status: Not yet recruiting

Contact:
Last name: Site 0101

Facility:
Name: Hopital Claude Huriez - CHU de Lille

Address:
City: Lille
Zip: 59000
Country: France

Status: Recruiting

Contact:
Last name: Franck Morschhauser, Site 0103

Phone: 33320445713

Facility:
Name: Local Institution - 0121

Address:
City: Poitiers
Zip: 86021
Country: France

Status: Not yet recruiting

Contact:
Last name: Site 0121

Facility:
Name: Hôpital Saint-Louis

Address:
City: Paris
Zip: 75010
Country: France

Status: Recruiting

Contact:
Last name: Catherine Thieblemont, Site 0118

Phone: 33142499236

Facility:
Name: Local Institution - 0197

Address:
City: Regensburg
Zip: 93049
Country: Germany

Status: Not yet recruiting

Contact:
Last name: Site 0197

Facility:
Name: Klinikum Chemnitz - Flemmingstraße

Address:
City: Chemnitz
Zip: 09116
Country: Germany

Status: Recruiting

Contact:
Last name: Mathias Haenel, Site 0188

Phone: 4937133344500

Facility:
Name: Gemeinschaftspraxis Hämatologie - Onkologie Freiberg-Richter, Jacobasch, Illmer, Wolf

Address:
City: Dresden
Zip: 01307
Country: Germany

Status: Recruiting

Contact:
Last name: Thomas Illmer, Site 0189

Phone: 00493514400022

Facility:
Name: Local Institution - 0198

Address:
City: Rome
Zip: 00133
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Site 0198

Facility:
Name: Local Institution - 0179

Address:
City: Rozzano
Zip: 20089
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Site 0179

Facility:
Name: Local Institution - 0096

Address:
City: Bari
Zip: 70124
Country: Italy

Status: Withdrawn

Facility:
Name: Local Institution - 0098

Address:
City: Bari
Zip: 70124
Country: Italy

Status: Withdrawn

Facility:
Name: Local Institution - 0097

Address:
City: Bari
Zip: 70124
Country: Italy

Status: Withdrawn

Facility:
Name: Local Institution - 0076

Address:
City: Bologna
Zip: 40138
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Site 0076

Facility:
Name: Local Institution - 0075

Address:
City: Napoli
Zip: 80131
Country: Italy

Status: Not yet recruiting

Contact:
Last name: Site 0075

Facility:
Name: Local Institution - 0104

Address:
City: Hwasun Gun
Zip: 58128
Country: Korea, Republic of

Status: Withdrawn

Facility:
Name: Pusan National University Hospital

Address:
City: Busan
Zip: 49241
Country: Korea, Republic of

Status: Recruiting

Contact:
Last name: Ho-Jin Shin, Site 0100

Phone: 821089371258

Facility:
Name: Seoul National University Hospital

Address:
City: Seoul
Zip: 03080
Country: Korea, Republic of

Status: Recruiting

Contact:
Last name: YOUNGIL KOH, Site 0085

Phone: 01091175012

Facility:
Name: Samsung Medical Center

Address:
City: Seoul
Zip: 06351
Country: Korea, Republic of

Status: Recruiting

Contact:
Last name: Won Seog Kim, Site 0086

Phone: 82-2-3410-6548

Facility:
Name: Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy

Address:
City: Bydgoszcz
Zip: 85-168
Country: Poland

Status: Recruiting

Contact:
Last name: Jaroslaw Czyz, Site 0186

Phone: 508508810

Facility:
Name: Luxmed Onkologia sp. z o. o.

Address:
City: Warszawa
Zip: 01-748
Country: Poland

Status: Recruiting

Contact:
Last name: Joanna Barankiewicz, Site 0185

Phone: +48223496303

Facility:
Name: Aidport

Address:
City: Skórzewo
Zip: 60-185
Country: Poland

Status: Recruiting

Contact:
Last name: Michal Kwiatek, Site 0187

Phone: +48793602210

Facility:
Name: Hospital Universitari Son Espases

Address:
City: Palma
Zip: 07120
Country: Spain

Status: Recruiting

Contact:
Last name: Antonio Gutierrez Garcia, Site 0196

Phone: +34871206268

Facility:
Name: Hospital Universitario Doctor Peset

Address:
City: Valencia
Zip: 46017
Country: Spain

Status: Recruiting

Contact:
Last name: Eva María Donato Martín, Site 0192

Phone: 34963189168

Facility:
Name: Hospital Universitario Fundacion Jimenez Diaz.

Address:
City: Madrid
Zip: 28040
Country: Spain

Status: Recruiting

Contact:
Last name: Raul Cordoba Mascuñano, Site 0191

Phone: +34649694829

Facility:
Name: Kaohsiung Medical University Chung-Ho Memorial Hospital

Address:
City: Kaohsiung
Zip: 807
Country: Taiwan

Status: Recruiting

Contact:
Last name: YI-CHANG LIU, Site 0094

Phone: 886-7-312110

Facility:
Name: Chang Gung Memorial Hospital at Kaohsiung

Address:
City: Kaohsiung
Zip: 83301
Country: Taiwan

Status: Recruiting

Contact:
Last name: Ming Chung Wang, Site 0092

Phone: 0975056053

Facility:
Name: National Taiwan University Hospital

Address:
City: Taipei
Zip: 10002
Country: Taiwan

Status: Recruiting

Contact:
Last name: Tai-Chung Huang, Site 0123

Phone: +886972651392

Facility:
Name: Local Institution - 0175

Address:
City: Southampton
Zip: SO16 0YD
Country: United Kingdom

Status: Not yet recruiting

Contact:
Last name: Site 0175

Facility:
Name: Kent and Canterbury Hospital

Address:
City: Canterbury
Zip: CT1 3NG
Country: United Kingdom

Status: Recruiting

Contact:
Last name: Moya Young, Site 0112

Phone: +441227864072

Facility:
Name: Western General Hospital

Address:
City: Edinburgh
Zip: EH4 2XU
Country: United Kingdom

Status: Recruiting

Contact:
Last name: Victoria Campbell, Site 0115

Phone: 01315371296

Facility:
Name: City Hospital, Nottingham University Hospitals NHS Trust

Address:
City: Nottingham
Zip: NG5 1PB
Country: United Kingdom

Status: Recruiting

Contact:
Last name: Mark Bishton, Site 0105

Phone: 01159691169

Start date: August 30, 2024

Completion date: November 27, 2028

Lead sponsor:
Agency: Celgene
Agency class: Industry

Source: Celgene

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06425302
https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
https://www.bmsclinicaltrials.com/us/en/clinical-trials/NCT06425302.html

Login to your account

Did you forget your password?